Journal of Family Medicine and Primary Care

CASE REPORT
Year
: 2015  |  Volume : 4  |  Issue : 1  |  Page : 135--136

Infantile hemangioma in a V2 distribution: Treatment with nadolol


Mariah Giberson, Robert Hayes 
 Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada

Correspondence Address:
Mariah Giberson
Dalhousie Medicine New Brunswick, 100 Tucker Park Road, PO Box 5050, Saint John, New Brunswick, E2L4L5
Canada

Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers have been favoured over systemic corticosteroids for treatment of disfiguring or life-threatening infantile hemangiomas. We present a case of an 11-week-old female with a 7 week history of an evolving hemangioma along a facial V2 distribution. Physical exam revealed a well-defined bright red plaque over the right zygoma and lower eyelid. MRI, echocardiograph, and liver ultrasound were normal. Patient was treated with nadolol and had a rapid and substantial regression of the hemangioma. Nadolol is an effective treatment option for disfiguring facial infantile hemangioma. The use of beta-blockers as treatment offers clues into the pathogenesis of infantile hemangioma, which is not yet completely understood


How to cite this article:
Giberson M, Hayes R. Infantile hemangioma in a V2 distribution: Treatment with nadolol.J Family Med Prim Care 2015;4:135-136


How to cite this URL:
Giberson M, Hayes R. Infantile hemangioma in a V2 distribution: Treatment with nadolol. J Family Med Prim Care [serial online] 2015 [cited 2019 Aug 24 ];4:135-136
Available from: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2015;volume=4;issue=1;spage=135;epage=136;aulast=Giberson;type=0